(Q40299399)

19 September 2017

title

Considerations for HPV primary screening in lower-middle income countries (English)

1 reference

19 September 2017

Mauricio Maza

1

1 reference

19 September 2017

Julia C Gage

series ordinal

2

1 reference

19 September 2017

language of work or name

English

0 references

publication date

6 February 2017

1 reference

19 September 2017

1 reference

19 September 2017

volume

98

1 reference

19 September 2017

page(s)

39-41

1 reference

The Peru Cervical Cancer Screening Study (PERCAPS): the design and implementation of a mother/daughter screen, treat, and vaccinate program in the Peruvian jungle.

19 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2016.12.029

New paradigms and challenges in cervical cancer prevention and control in Latin America

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2016.12.029

Use of HC2 to triage women with borderline and mild dyskaryosis in the UK.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2016.12.029

Effect of self-collection of HPV DNA offered by community health workers at home visits on uptake of screening for cervical cancer (the EMA study): a population-based cluster-randomised trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2016.12.029

HPV testing: a mixed-method approach to understand why women prefer self-collection in a middle-income country

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2016.12.029

Good Health at Low Cost 25 years on: lessons for the future of health systems strengthening

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2016.12.029

HPV-FASTER: broadening the scope for prevention of HPV-related cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2016.12.029

Global estimates of human papillomavirus vaccination coverage by region and income level: a pooled analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2016.12.029

Resources Required for Cervical Cancer Prevention in Low- and Middle-Income Countries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2016.12.029

Risk assessment to guide the prevention of cervical cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2016.12.029

Introduction of human papillomavirus DNA screening in the world: 15 years of experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2016.12.029

Introducing a High-Risk HPV DNA Test Into a Public Sector Screening Program in El Salvador

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2016.12.029

Human papillomavirus types in 115,789 HPV-positive women: a meta-analysis from cervical infection to cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2016.12.029

Present status of human papillomavirus vaccine development and implementation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2016.12.029

Implementation of HPV testing in Latin America

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2016.12.029

Benchmarking CIN 3+ risk as the basis for incorporating HPV and Pap cotesting into cervical screening and management guidelines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2016.12.029

Evaluation of a 5-year cervical cancer prevention project in Indonesia: opportunities, issues, and challenges

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2016.12.029

Self-collection of vaginal specimens for human papillomavirus testing in cervical cancer prevention (MARCH): a community-based randomised controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2016.12.029

Tuberculosis control and elimination 2010–50: cure, care, and social development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2016.12.029

2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2016.12.029

Cervical cancer screening programs in Latin America and the Caribbean.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2016.12.029

Population-level scale-up of cervical cancer prevention services in a low-resource setting: development, implementation, and evaluation of the cervical cancer prevention program in Zambia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2016.12.029

Cervical cancer screening using visual inspection with acetic acid: operational experiences from Ghana and Thailand

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2016.12.029

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2016.12.029

Human papillomavirus and cervical cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2016.12.029

Time for a Model List of Essential Diagnostics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2016.12.029

Introduction of molecular HPV testing as the primary technology in cervical cancer screening: Acting on evidence to change the current paradigm

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2016.12.029

Approaches for triaging women who test positive for human papillomavirus in cervical cancer screening

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2016.12.029

10.1016/J.YPMED.2016.12.029

7 January 2021

Identifiers

DOI

1 reference

19 September 2017

1 reference